亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

anti-HLA-DR, -DQ and -DP beta chains mAb LGII-612.14 and hybridoma cell line

詳細技術說明
None
*Abstract
Major histocompatibility complex (MHC) is a cell surface molecule that mediates interactions with immune cells thru the presentation of peptides. MHC is dived into three groups; class I, class II, and class III. MHC class II is formed of two chains, ╬▒ and ╬▓, each having two domains ╬▒1 and ╬▒2 and ╬▓1 and ╬▓2. ╬▒2 and ╬▓2 function as the transmembrane domain, anchoring the MHC molecule to the cell membrane. The peptide binding groove is formed of the heterodimer of ╬▒1 and ╬▓1.The human leukocyte antigen (HLA) is the corresponding name of the major histocompatibility complex (MHC) in humans. HLA molecules are divided into two subgroups; class I and II. HLA class II molecules (DP, DM, DOA, DOB, DQ, and DR) present extracellular antigens to T-lymphocytes.Monoclonal antibody LGII-612.14 recognizes the beta chains of the HLA -DR, -DQ and -DP. Validated Uses:Western BlotImmunopercipitationImmunohistochemistry-Formalin Fixed TissueReferences:J. Immunol. Methods 161:239-256, 1993Available for non commercial license as a research tool
*Principal Investigation

Name: Soldano Ferrone, Professor

Department: Department of Surgery

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備